Infertility Clinical Trial
Official title:
Graceful Lifestyle Changes Intervention Study for Women With PCOS and Infertility
The purpose of this study is to help women with PCOS to improve their symptoms and ovulation rate through a lifestyle intervention program which introduces a specific diet, a physical activity regimen and mindfulness exercises to improve psychological well-being and overall health.
1) Purpose
The purpose of this study is to:
1. assess if implementing lifestyle changes through instruction and coaching is as
effective as standard ovulation-induction therapy,
2. evaluate if myo-inositol is an effective addition to both lifestyle intervention and
standard fertility medications, and
3. evaluate how each of four main sub-types of PCOS will respond to our lifestyle
intervention program.
2) Hypothesis:
The investigators hypothesize that implementing lifestyle changes in women with PCOS will
help restore ovulation by balancing reproductive hormones and increasing sensitivity to
insulin. Lifestyle changes will also help to manage common PCOS symptoms and therefore,
increase psychological well-being and quality of life in this population of women. In
addition to a low-glycemic diet, physical activity, and stress reduction, a diet
supplemented with myo-inositol will create further hormonal homeostasis and improve
metabolic functioning. Finally, the investigators believe that the distinct sub-types of
PCOS will respond differently to the proposed lifestyle intervention program and therefore,
this will demonstrate that diet, activity and stress reduction is an effective approach to
fertility for some individuals, but not others.
3) Justification:
Polycystic ovary syndrome (PCOS) is a heterogenous condition characterized by chronic
anovulation and increased androgens (either as clinical or biochemical manifestations)
according to the original NIH criteria. Since then, polycystic ovaries on ultrasound
assessment has been included as an additional feature in the Rotterdam criteria and a
diagnosis is made if a woman has any two of these three features. Very little information is
known about why PCOS can present differently among individuals and which lifestyle factors
are the cause or the effect. Many women with PCOS have difficulty conceiving due to
infrequent ovulation. Evidence suggest that diet, activity and stress levels influence
ovulation and affect the response of the ovaries to fertility medications or pregnancy
success to fertility treatments.
To this date, there have been no studies conducted incorporating diet, exercise, and stress
reduction in a cohesive intervention program for women with PCOS trying to conceive. Recent
studies have suggested that women with PCOS can significantly benefit from specific
lifestyle changes such as eating a low glycemic diet, increasing activity level, and
reducing stress however, these studies have had several limitations such as high-drop out
rates, lack of PCOS phenotypes included, and small cohort sizes. Also, most studies have
focused on only one major lifestyle change, such as diet, which is not as powerful as
combining diet, exercise and stress reduction. Finally, mindfulness and meditation as a
means to decrease stress has yet to be studied in a PCOS cohort. The relaxation response is
a powerful tool that has been proven to be effective in stress-related diseases such as
cancer, cardiovascular disease and mental disorders. Since women with PCOS tend to have high
levels of stress, inducing the relaxation response through mindfulness may be an effective
treatment for this cohort.
4) Objectives
1. To determine if lifestyle changes are effective at restoring ovulation without the use
of a commonly used fertility treatment.
2. To determine if myo-inositol improves the restoration of ovulation and insulin
resistance in women with polycystic ovary syndrome (PCOS).
3. To evaluate how each of four main sub-types of PCOS will respond to our lifestyle
intervention program.
5) Research Method:
Women with PCOS will be randomly assigned to one of two groups: the GLC group, which will
participate in our "Graceful Lifestyle Changes" program and an oral fertility medication
group, which will be prescribed letrozole. Within each of these two groups, participants
will be further divided randomly to consume either myo-inositol or a placebo.
The GLC group will meet with physicians and educators, in small groups of 8-10 participants,
once a week for 12 weeks. Each week will consist of an educational portion which will coach
women on how to consume a low-glycemic diet, the benefits of walking 10,000 steps a day, and
how to induce the relaxation response to decrease stress. A wellness booklet designed and
provided by clinicians at Grace Fertility Centre will outline the main ideas being taught.
Participants in the GLC group will be required to record their daily food intake to maintain
a daily target of 45% carbohydrates and 55 grams of glycemic load a daily, which is similar
to previous low-glycemic diet intervention studies. Lists will be provided outlining foods
that are either low, medium, or high in glycemic load. Participants will be advised to eat
as many low glycemic foods as possible and to limit the high glycemic load foods. They will
also be provided with a pedometer to measure the number of steps being walked each day.
Lastly, these participants will practice relaxation response exercises for twenty minutes
each day and will record which exercises they performed in their daily diary.
Participants will complete a 3-day diet diary report as well as a physical activity report
based on their pedometer recordings during the baseline, 4th, 8th, and 12th weeks.
Participants will also receive a phone call from a trained researcher to complete a 24-hour
diet recall at the end of the 2nd, 6th, and 10th weeks. This recall will assess all food
consumed in the previous 24 hours. These combined methods will aim to:
- assess overall compliance to the low-glycemic diet
- provide information on the length of time participants take to comply
- evaluate any fluctuations in eating habits
- compare two types of nutritional assessment to each other
Compliance to the physical activity portion will be measured through daily pedometer
recordings made by the participant. Compliance to the meditation and relaxation exercises
will be measured by daily reports. Compliance will be ensured additionally through weekly
check-ins/weigh-ins, weekly education sessions, and frequent email reminders with tips and
motivators to stay on track.
The use of clomiphene citrate to treat anovulatory infertility is common. However, in
agreement with what the investigators have observed in clinical practice, recent evidence
has suggested that letrozole is more effective than clomiphene citrate in achieving
ovulation. Additionally, letrozole may be more beneficial since it does not negatively
affect the endometrial thickness. However, up to 40% of women may not ovulate with oral
fertility treatments alone. Newer evidence suggests that diet, activity and stress levels
influence ovulation and affect the response of the ovaries to fertility treatments.
;
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A |